NEWS

Current Position: Home>>News>>Biological News

Search articles:

News

Immune cells in the intestine have a sweet tooth

Immune cells in the intestine have a sweet tooth

Associate Professor at FMUL and published today in the scientific journal PNAS discovered that white blood cells that reside in the intestines, a specific group of immune cells called tissue resident lymphocytes, use sugar as an energy source and have a faster metabolism than lymphocytes that circulate in the blood.
Read More
16
Aug,2022
A new perspective in how immunity is fine-tuned through mechanics

A new perspective in how immunity is fine-tuned through mechanics

Traditional research posits that parts of invading pathogens or cells sound the alarm, but accumulating evidence suggests that the physical environment surrounding immune cells may also play an active role in the early recognition of danger and in the initiation of immune responses.
Read More
16
Aug,2022
Interference factors of simultaneous increase of T3, T4 and TSH

Interference factors of simultaneous increase of T3, T4 and TSH

Recently, the clinical laboratory scholars of Cleveland Clinic (the second largest medical group in the United States, second only to Mayo Clinic) reported a case where the test results of T3, T4, FT3 and FT4 were inaccurate due to the interference of autoantibodies.
Read More
16
Aug,2022
Nature aging is a &quotlife prolonging" vaccine that removes aging cells?

Nature aging is a "life prolonging" vaccine that removes aging cells?

Aging is a natural process. With the growth of age, all people will gradually grow old, which seems to be an unchangeable natural law.
Read More
16
Aug,2022
Targeted Plasma Proteomics to Predict the Development of Carotid Plaques

Targeted Plasma Proteomics to Predict the Development of Carotid Plaques

Cardiovascular risk stratification in primary prevention is a clinical challenge. We recently identified a large set of circulating proteins improving the risk prediction for cardiovascular events.
Read More
09
Aug,2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques

A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques

Clade C HIV-1 infections are responsible for a large proportion of global HIV-1 burden, and a vaccine is urgently required.
Read More
09
Aug,2022

About Us

Company Information

Photo albums

Privacy statement

Uniprot | NCBI | R&D | T&I | IB | ARP Cookie Policy  ©2023-2025 Wuhan Abebio Science Co.,Ltd All Rights Reserved.